Inadvertent sub-macular triamcinolone during pars plana vitrectomy for epiretinal membrane: A case report.

IF 3.3 4区医学 Q1 Medicine

European review for medical and pharmacological sciences Pub Date : 2025-05-01 DOI:10.26355/eurrev_202505_37221

T Erakgün, H H Gobeka

{"title":"Inadvertent sub-macular triamcinolone during pars plana vitrectomy for epiretinal membrane: A case report.","authors":"T Erakgün, H H Gobeka","doi":"10.26355/eurrev_202505_37221","DOIUrl":null,"url":null,"abstract":"BACKGROUND: The study aims to describe an inadvertent sub-macular triamcinolone acetonide (TA) deposition following a TA-assisted pars plana vitrectomy (PPV) for epiretinal membrane (ERM) peeling. CASE REPORT: In this interventional case report, a 75-year-old female with ERM-induced visual distortion underwent TA-assisted 25-gauge three-port PPV, endolaser photocoagulation, and sulfur hexafluoride (SF6) gas (8%) endo tamponade to treat ERM in the left eye. Significant TA deposition was observed intraoperatively in the submacular region, which remained after ERM and internal limiting membrane (ILM) removal. One month after PPV, the retina appeared flat, with no significant vitreoretinal interface defects or macular ultrastructural abnormalities. Vision improved from 0.40 to 0.2 logMAR, and there was no evidence of any ophthalmoscopic damage. CONCLUSIONS: Inadvertent sub-macular TA deposition following ERM peeling did not cause any significant surgical sequelae.Graphical abstract: https://www.europeanreview.org/wp/wp-content/uploads/Graphical-Abstract-13.jpg.","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 5","pages":"225-230"},"PeriodicalIF":3.3000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European review for medical and pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26355/eurrev_202505_37221","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

BACKGROUND: The study aims to describe an inadvertent sub-macular triamcinolone acetonide (TA) deposition following a TA-assisted pars plana vitrectomy (PPV) for epiretinal membrane (ERM) peeling. CASE REPORT: In this interventional case report, a 75-year-old female with ERM-induced visual distortion underwent TA-assisted 25-gauge three-port PPV, endolaser photocoagulation, and sulfur hexafluoride (SF6) gas (8%) endo tamponade to treat ERM in the left eye. Significant TA deposition was observed intraoperatively in the submacular region, which remained after ERM and internal limiting membrane (ILM) removal. One month after PPV, the retina appeared flat, with no significant vitreoretinal interface defects or macular ultrastructural abnormalities. Vision improved from 0.40 to 0.2 logMAR, and there was no evidence of any ophthalmoscopic damage. CONCLUSIONS: Inadvertent sub-macular TA deposition following ERM peeling did not cause any significant surgical sequelae.

Graphical abstract: https://www.europeanreview.org/wp/wp-content/uploads/Graphical-Abstract-13.jpg.

查看原文本刊更多论文

黄斑下曲安奈德治疗视网膜前膜玻璃体切除术1例。

背景：该研究旨在描述TA辅助玻璃体切割（PPV）视网膜前膜（ERM）剥离后黄斑下曲安奈德（TA）沉积。病例报告：在这一介入性病例报告中，一位75岁的女性因ERM引起的视觉扭曲接受了ta辅助的25号三口PPV，内激光光凝和六氟化硫（SF6）气体（8%）内压填塞治疗左眼ERM。术中在黄斑下区域观察到明显的TA沉积，在ERM和内限制膜（ILM）去除后仍然存在。PPV术后1个月，视网膜变平，无明显玻璃体视网膜界面缺损及黄斑超微结构异常。视力从0.40 logMAR改善到0.2 logMAR，没有任何检眼镜损伤的证据。结论：ERM剥离后黄斑下TA沉积不引起任何明显的手术后遗症。图形摘要：https://www.europeanreview.org/wp/wp-content/uploads/Graphical-Abstract-13.jpg。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European review for medical and pharmacological sciences 医学-药学

CiteScore

5.30

自引率

6.10%

发文量

906

审稿时长

2-4 weeks

期刊介绍： European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine. European Review for Medical and Pharmacological Sciences includes: -Editorials- Reviews- Original articles- Trials- Brief communications- Case reports (only if of particular interest and accompanied by a short review)